Genentech

Oct 8, 2024, 15:11 | Blog

Ashley Magargee: My 20th anniversary at Genentech

Ashley Magargee shared on LinkedIn: "Last month officially marked my 20th anniversary at Genentech! I…

Oct 2, 2024, 14:06 | Blog

Aakash Desai: Excited for the IMPACT-NSCLC study presented at ASCO Quality Care Symposium

Aakash Desai, Assistant Professor, UAB O'Neal Comprehensive Cancer Center, shared a post by Shashi Shankar,…

Sep 26, 2024, 13:58 | Blog

Renjith Vijayakumar Selvarani: A Turning Point for Cancer Vaccines

Renjith Vijayakumar Selvarani, Founder, Chairman, Chief Scientific and Technology Officer at OLUSIUM, shared a post…

Sep 14, 2024, 10:15 | Career

Melinda Aldrich has been appointed to the ASHG Board of Directors

Melinda Aldrich was recently elected to the (American Society of Human Genetics) ASHG Board of…

Aug 11, 2024, 21:32 | Blog

Full power of innovation to achieve the goals of The White House Cancer Moonshot initiative - Genomate Health

Genomate Health posted on LinkedIn: "As a CancerX Moonshot founding member, we collaborate with other…

Aug 11, 2024, 19:26 | Blog

Know Your Biomarkers: The 'Ask About ALK' Campaign

ALK Positive Inc. posted on LinkedIn: "Sponsored by Genentech. When Nikki was diagnosed with lung…

Aug 8, 2024, 11:55 | Blog

Why it’s important to talk to a healthcare provider about biomarker testing - ALK Positive Inc.

ALK Positive Inc. shared a post on LinkedIn: ''Sponsored by Genentech. For Mike, finding out…

Jul 24, 2024, 14:01 | Blog

Eleni Taoula: Complex global regulatory landscape for ADCs

Eleni Taoula, Associate Professor at The University of Nicosia Medical School, shared on LinkedIn: "ADC drugs…

Jul 22, 2024, 16:46 | Insight

Friends HRD Harmonization Project with Patsy Hinson - Friends of Cancer Research

Friends of Cancer Research shared on X: "It is very important for patients to have…

Jul 2, 2024, 10:32 | Insight

Trastuzumab emtansine (T-DM1) is highly effective in preventing stage 1 HER2-positive breast cancer from recurring - MedEdge MEA

MedEdge MEA shared a post on LinkedIn: . "A year of treatment with a medicine…

Jun 29, 2024, 15:03 | Insight

IO inductive therapy let 25% unresectable stage 3 NSCLC become resectable

Thomas Wu, Research physician at Genentech, shared a post by X: "Our paper just out…

Jun 9, 2024, 08:07 | Blog

Ashley Magargee: I am so proud that Genentech is part of the Biden Cancer Moonshot program

Ashley Magargee, Chief Executive Officer at Genentech, shared a post by Genentech on LinkedIn: "We…

May 23, 2024, 20:08 | Blog

Maria Babak: Join the UNITY Summit organized by The University of Illinois Cancer Center and don't forget about the OncoParty2024

Maria Babak shared a post by Shikha Jain on LinkedIn: "If you are attending ASCO this year,…

May 16, 2024, 16:51 | Insight

10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily

In the fast-growing field of oncology, we are witnessing significant advances in several treatment modalities…

May 12, 2024, 15:42 | Insight

Sumanta Pal: Proud of this project on two levels

Sumanta Pal, Professor in the Department of Medical Oncology at City of Hope Medical Center,…

May 11, 2024, 00:51 | Career

Joni Fausett: I joined Kite Pharma as the Head of US Medical Affairs

Joni Fausett, Head of US Medical Affairs at Kite Pharma, made the following post on…

May 9, 2024, 15:31 | Blog

Hedyeh Ebrahimi: Unique challenges that community cancer centers face to engage in oncology clinical trials

Hedyeh Ebrahimi, Postdoctoral fellow at Genitourinary Cancer Research Team of City of Hope, shared a post…

May 7, 2024, 13:55 | Blog

Karen Knudsen: Genentech reflects the depth and breadth of our commitments to improving the lives of cancer patients

Karen Knudsen shared a post by American Cancer Society on LinkedIn, adding: "Our work with…

Apr 23, 2024, 10:07 | Insight

Ashley Magargee: Fortunate to have leading computational biology experts like Aviv Regev advancing our understanding of cancer like never before

Ashley Magargee, Chief Executive Officer at Genentech, shared on LinkedIn: "We’re fortunate to have leading…

Apr 19, 2024, 15:52 | Drugs

FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer based on ALINA trial

FDA, the Food and Drug Administration approved alectinib (Alecensa, Genentech, Inc.) for adjuvant treatment following…

Apr 13, 2024, 09:17 | Societies

30 Posts Not To Miss From AACR24!

The AACR Annual Meeting 2024 was held from April 5th to 10th in San Diego,…

Apr 10, 2024, 08:53 | Insight

Vivek Subbiah: Cell atlas projects have contributed to our understanding of cancers

Vivek Subbiah shared on X/Twitter: "We have learned a lot from cell atlas projects -…

Feb 23, 2024, 17:26 | Blog

Elad Sharon: Honored to receive a plaque for our team’s work getting the first immune checkpoint inhibitor approved in sarcoma!

Elad Sharon, Medical Oncologist at Dana-Farber Cancer Institute, made the following post on X: "Honored…

Dec 13, 2023, 11:08 | Career

Genentech Welcomes Ashley Magargee as New CEO: A 20-Year Journey of Excellence and Leadership

Genentech shared today on LinkedIn: "We are excited to share that Ashley Magargee has been…

Dec 10, 2023, 17:54 | Blog

Christian Rutzer: Roche and Novartis - Basel's Research and Innovation Powerhouses

Christian Rutzer, Deputy Head and Lead Scientist at the CIEB University of Basel, shared on…

Nov 23, 2023, 15:53 | Blog

David Paragamian: Our Recently Diagnosed? Podcast is a Gold MarCom Award-winner

David Paragamian, Chief Executive Officer at Health Monitor Network, posted on LinkedIn: "Our Recently Diagnosed?…

Oct 12, 2023, 01:34 | Opinion

Alexander Hardy: Today, we're commemorating a significant milestone at Genentech - the 25th anniversary of a groundbreaking medicine for patients with HER2+ metastatic breast cancer.

Aug 3, 2023, 19:36 | Blog

I look forward to relocating back to the east coast to begin a new adventure in drug discovery and development - Mark McCarron

A professor and a venture capitalist walk into a bar…and the rest is history. I’ve…

All: 28 Posts: 1 - 100